Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
about
Oligodendrogenesis in the normal and pathological central nervous systemMultiple sclerosis: molecular mechanisms and therapeutic opportunitiesNatural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisProtective and detrimental roles for regulatory T cells in a viral model for multiple sclerosisAn update on the biology of sphingosine 1-phosphate receptors.Coronavirus-induced demyelination of neural pathways triggers neurogenic bladder overactivity in a mouse model of multiple sclerosis.Characterization of oligodendroglial populations in mouse demyelinating disease using flow cytometry: clues for MS pathogenesis.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.RORγt, but not T-bet, overexpression exacerbates an autoimmune model for multiple sclerosis.Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.Altered protein networks and cellular pathways in severe west nile disease in mice.Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis).Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules.Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis.PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisHigh-Resolution Diffusion Tensor Spinal Cord MRI Measures as Biomarkers of Disability Progression in a Rodent Model of Progressive Multiple Sclerosis.Association of Autophagy in the Cell Death Mediated by Dihydrotestosterone in Autoreactive T Cells Independent of Antigenic Stimulation.Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune Disease.Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.An introduction to biomaterial-based strategies for curbing autoimmunity.Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosis.Interactions between neutrophils, Th17 cells, and chemokines during the initiation of experimental model of multiple sclerosis.A biodegradable nanoparticle platform for the induction of antigen-specific immune tolerance for treatment of autoimmune disease.A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.Alarmin' Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent ResponsesClose Encounters of the First Kind: Innate Sensors and Multiple Sclerosis.Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice.Top 10 research questions related to physical activity and multiple sclerosis.Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis.The more the merrier? Scoring, statistics and animal welfare in experimental autoimmune encephalomyelitis.Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.Myeloperoxidase: A new player in autoimmunity.New Frontiers of Basic Science Research in Neurogenic Lower Urinary Tract Dysfunction.Treatment of Theiler's virus-induced demyelinating disease with teriflunomide.Spontaneous germinal centers and autoimmunity.Kallikrein-related peptidase 6 exacerbates disease in an autoimmune model of multiple sclerosis.Cytokine Signaling in Multiple Sclerosis and Its Therapeutic Applications.Chronic demyelination-induced seizures.Splitting the "Unsplittable": Dissecting Resident and Infiltrating Macrophages in Experimental Autoimmune Encephalomyelitis.
P2860
Q21129352-5F7E13C8-ED6B-4847-98E9-BA80ABB42ABBQ27023735-A7737B88-6230-4D4D-A0C0-EE643B4301CFQ28085038-CC681677-80B9-4D0A-911A-1543F1A71A34Q33901171-24529A34-E23F-43CA-B09C-4A682AE52AE7Q33945064-AB1F9A7F-F0F7-45B7-B501-FF8F067B2324Q34131056-E0F117C1-1C32-43CA-B730-7263A1D5DD41Q34232425-5794CDD8-B17B-419B-BF48-3E0872DC74DAQ34468304-86931315-B057-49BC-A256-E018977FF542Q34613664-2C38F4BD-79AB-4771-B679-270D870F47D1Q34646572-F66E6DA1-DEAA-4D9B-8899-AAC349AF7A96Q34847941-7D6796C7-DECD-407B-8223-D3A860DD19ABQ35498194-64D8779D-2DEC-409C-A083-14D38D942316Q35879035-235E1EEE-E197-42C3-8100-63E3A8B955A0Q35964276-D3DD2858-C30D-4A88-A4AA-2D4DDC60A246Q36016406-82CC9B75-8FD7-4379-B7E5-862A5941FA06Q36088855-3BF08438-D3F7-4BD1-82AA-B71DC0008860Q36326808-31BEFA75-150F-4365-9859-1563063D7C3BQ36553718-4F8ADE78-D6AA-43C1-923D-EB147AFF5921Q36755979-9B6826C3-96B1-468E-8CF6-8CC6B2B87198Q37107172-76D51D8A-DE18-42DA-8FDF-1C2726D6B933Q37183047-0D175AB8-C8E6-427B-92C1-B4035BB59FE8Q37623410-0464D345-2E1A-4001-887F-7387176D6DB5Q37708089-B00AAC39-EDA1-4F50-A953-B9C58FB1CCF1Q38258366-EB28045A-3400-4510-BD97-10B176DB6632Q38530106-CDF0FBDB-87BB-4AC0-8E62-3D3DB513B1C6Q38687394-8C529B1A-9CEB-4A8C-81E7-0FFF546F854DQ38693428-44A4ADA4-81E0-486E-8488-9619FF783F72Q38700383-694DDD81-4DD3-495B-98C4-B08F81649086Q39018023-DED834BD-5D5D-4A4B-85DB-53407F7A777BQ39136258-3E1945D5-83DA-4F96-B585-A2922A485BAEQ39137953-7F4046B7-74A8-4A6E-A7B7-CE52476B0C47Q39150957-AE58B705-ECE9-436D-A73E-A4417DD0A6FFQ39311970-F70C6214-4890-4093-B92C-B6ED06030D80Q39439674-6A2033EB-A107-405D-B1A9-352914E7D2C9Q40039485-0221E0E7-039E-42D9-B702-158BC5BAF696Q40343247-3C462E51-C0A8-440F-8C2E-BD61FE4715EFQ45049071-5710256D-907C-4FD3-9900-C001430BC33AQ45071794-C524108B-046C-44AF-B336-0E5F92F4B01DQ46468122-CB6F7763-F295-4D1C-BECB-CAEE295F3A8DQ47118345-B1C5C403-7C39-43B5-B874-CD30C1180F35
P2860
Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Mouse models of multiple scler ...... induced demyelinating disease.
@ast
Mouse models of multiple scler ...... induced demyelinating disease.
@en
type
label
Mouse models of multiple scler ...... induced demyelinating disease.
@ast
Mouse models of multiple scler ...... induced demyelinating disease.
@en
prefLabel
Mouse models of multiple scler ...... induced demyelinating disease.
@ast
Mouse models of multiple scler ...... induced demyelinating disease.
@en
P2093
P2860
P1476
Mouse models of multiple scler ...... induced demyelinating disease.
@en
P2093
Derrick P McCarthy
Maureen H Richards
Stephen D Miller
P2860
P304
P356
10.1007/978-1-60761-720-4_19
P407
P577
2012-01-01T00:00:00Z